6215.5000 139.00 (2.29%)
NSE May 14, 2025 15:31 PM
Volume: 576.3K
 

Axis Direct
We are positively surprised on fast remediation by Divi's followed by quick USFDA re-inspection. Form 483 observations issued in Dec 16 on Unit 2 facility (under Import Alert) have been confirmed as completed and resolved (EIR awaited) after USFDA re-inspection.
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended